Live from the NIH registry
Studies recruiting near Spartanburg right now
Top 25 of 363 recruiting studies, sorted by proximity — each links to its official registry page
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Greenville, South Carolina (27.3 mi)
· Sponsor: AstraZeneca
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (27.3 mi)
· Sponsor: Dren Bio
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Spartanburg Medical Center — Spartanburg, South Carolina (0.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Saint Francis Hospital — Greenville, South Carolina (27.3 mi)
· Sponsor: NRG Oncology
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
Palmetto Clinical Trial Services, LLC — Greenville, South Carolina (27.3 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Altesa Biosciences, Inc.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
Bon Secours St. Francis Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: Sellas Life Sciences Group
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (27.3 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Greenville, South Carolina (27.3 mi)
· Sponsor: AstraZeneca
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (27.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Francis Hospital — Greenville, South Carolina (27.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Other
N/A
Interventional 97 participants sought
Spartanburg Medical Center — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Wake Forest University Health Sciences
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research, LLC- Greer — Greer, South Carolina (17.1 mi)
· Sponsor: Pfizer
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
Prisma Health - Upstate — Greenville, South Carolina (27.3 mi)
· Sponsor: Integra LifeSciences Corporation
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Carolina Nephrology, PA — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
FebriDx® Pediatric Validation Study
Acute Respiratory Infections (ARIs)
N/A
Observational 800 participants sought
Tribe- Parkside Pediatrics — Greenville, South Carolina (27.3 mi)
· Sponsor: Lumos Diagnostics
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
Prisma Health Upstate — Greenville, South Carolina (27.3 mi)
· Sponsor: SurModics, Inc.